SC 13G Filing

Company

Niagen Bioscience, Inc.

Filed

June 4, 2010

Accession Number

0001144204-10-031945

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →